Biotechnology
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

$40M

Market Cap • 12/20/2024

2021

(3 years)
Founded

2022

(2 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Chicago

Headquarters • Illinois